Company intelligence
Beacon Biosignals
Our mission is to improve human health by enabling rapid, targeted interventions through advanced brain analytics.
About Beacon Biosignals
Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain. Want to join the team? We’re hiring—check out the careers page on our website for more. Please be advised that Beacon Biosignals does not ask for personal information outside of our official hiring process. If a role is not listed on our careers page, it is not an active job opening. We will never ask candidates to send money to supplement company equipment, and all official emails from our team will come from the @beacon.bio domain, never text messages or Teams messages.
Verified activity
Signals from Beacon Biosignals
6 published signals
Presence & Recognition
Beacon Biosignals will present research at the ISCTM 2026 Autumn Conference on its Waveband and sleep staging algorithms matching trained sleep expert assessments for cortical arousals.
Reported by Beacon Biosignals
People
Beacon Biosignals has a dedicated Clinical Study Operations team led by Emily Mitchell, Vice President of Clinical Study Operations, with over 20 years of global clinical research experience.
Reported by Beacon Biosignals
Presence & Recognition
Beacon Biosignals is attending the Texas Society of Sleep Professionals Annual Conference in Round Rock from September 11 to 12 to speak directly with sleep professionals about home sleep testing and sleep diagnostics.
Reported by Craig P. Gallivan, MBA
People
Beacon Biosignals employee Emily Mitchell has been observed interacting directly with prospective customers to bring clarity, listen carefully, and create confidence in clinical trial conversations.
Reported by Craig P. Gallivan, MBA
Presence & Recognition
Beacon Biosignals is hosting a live Q&A discussion on how sleep could help reshape Alzheimer’s Disease trials on September 2, 2026, featuring experts including Joe Winer, Jacobo Mintzer, Jay Pathmanathan, and Dave Samuelson.
Reported by Beacon Biosignals
Presence & Recognition
Beacon Biosignals is attending the RAPSConvergence conference in Charlotte, North Carolina on Thursday, September 17, 2026, featuring Tahir Rizvi discussing PCCPs across the device lifecycle.
Reported by Beacon Biosignals